Clinical experience with primary cardiac tumors.
- Author:
Won Jae LEE
1
;
Hyun Su JO
;
Jang Won SON
;
Jun Cheol YOON
;
Chang Woo SON
;
Kyu Hwan PARK
;
Sang Hee LEE
;
Geu Ru HONG
;
Jong Sun PARK
;
Dong Gu SHIN
;
Young Jo KIM
;
Dong Heon YANG
;
Hun Sik PARK
;
Chang Wook NAM
;
Seung Ho HUR
;
Ji Yong CHOI
;
Kee Sik KIM
;
Jun Ho BAE
;
Deuk Young NAH
;
Bong Ryeol LEE
;
Byung Chun JUNG
Author Information
1. Division of Cardiology, Department of Internal Medicine, Yeungnam University Hospital, Daegu, Korea. grhong@med.yu.ac.kr
- Publication Type:Original Article
- Keywords:
Cardiac tumor;
Myxoma
- MeSH:
Autopsy;
Biopsy;
Chest Pain;
Dyspnea;
Fibroma;
Follow-Up Studies;
Heart Atria;
Heart Neoplasms;
Hospitals, Community;
Humans;
Incidence;
Korea;
Leiomyoma;
Lymphoma;
Medical Records;
Myxoma;
Retrospective Studies;
Rhabdomyoma;
Sarcoma;
Survival Rate;
Thrombosis
- From:Korean Journal of Medicine
2010;79(3):271-276
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: In Korea, few studies have examined primary cardiac tumors, which have a reported incidence of 0.0017~0.19% in autopsy series. This study surveyed the status of primary cardiac tumors over the past 7 years in one region. METHODS: A retrospective review examined all patients with primary cardiac tumors, except for confirmed thrombus, using hospital medical records from 2000 to 2006 at six community hospitals. Identified cases undergoing biopsy and surgery were selected for the study. RESULTS: The operative mortality was 7.7%. Of the 71 patients (26 males) with identified primary cardiac tumors, 65 (91.5%) tumors were benign and 6 (8.5%) were malignant. The benign tumors were myxoma (78.9%), rhabdomyoma (4.2%), fibroelastoma (2.8%), fibroma (1.4%), and leiomyoma (1.4%). Two of the myxomas were present at multiple locations. The malignant tumors included sarcomas (67%) and lymphomas (33%). Most of the tumors were located in the left atrium (76%). The majority of patients presented with chest pain and dyspnea. During follow-up for an average of 26.8+/-21.3 months, all but one patient with benign tumors was alive; one myxoma patient died perioperatively (1.5%). Four of the patients with malignant tumors (67%) died. CONCLUSIONS: Cardiac myxomas and sarcomas were the most common primary benign and malignant tumors, respectively. Benign tumors had excellent postoperative survival rates, while malignant tumors had high mortality.
